Management of Older Men With Clinically Localized Prostate Cancer: The Significance of Advanced Age and Comorbidity

被引:15
|
作者
Hoffman, Karen E. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
关键词
ANDROGEN-DEPRIVATION THERAPY; QUALITY-OF-LIFE; EXTERNAL-BEAM RADIOTHERAPY; CONGESTIVE-HEART-FAILURE; BONE-MINERAL DENSITY; LEAN BODY-MASS; RADICAL PROSTATECTOMY; SUPPRESSION THERAPY; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION;
D O I
10.1016/j.semradonc.2012.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The majority of men diagnosed with prostate cancer are diagnosed later in life. Although localized prostate cancer is often an indolent disease, older men are more frequently diagnosed with high-risk disease and are more likely to die from prostate cancer than younger men. Comorbid medical conditions are also more prevalent in the later decades of life and can impact prostate cancer treatment tolerance and the likelihood of benefiting from aggressive cancer treatment. Older men diagnosed with prostate cancer are at risk for both overtreatment of low-risk disease and undertreatment of high-risk disease. Prostate cancer management decisions for older patients should be tailored based on an individual patient's health status, coexisting medical conditions, life expectancy, and tumor characteristics. Semin Radiat Oncol 22:284-294 (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:284 / 294
页数:11
相关论文
共 50 条
  • [1] The use of brachytherapy for the treatment of clinically localized prostate cancer in older aged men
    Underwood, W
    Copeland, L
    Elshaikh, M
    Penner, L
    Jackson, J
    [J]. GERONTOLOGIST, 2005, 45 : 10 - 10
  • [2] Impact of comorbidity and age on treatment choice among men with localized prostate cancer.
    Pinsky, Paul F.
    Pierre-Victor, Dudith
    Martin, Iman K.
    Miller, Eric
    McCaskill-Stevens, Worta J.
    Grubb, Robert L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Radical prostatectomy in younger men (age <60) with clinically localized prostate cancer
    Chang, Peter
    Tewari, Ashutosh K.
    Raman, Jay D.
    Rao, Sandhya
    Divine, George
    Menon, Mani
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 530 - 530
  • [4] THE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    BERNSTEIN, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (19): : 2727 - 2730
  • [5] Conservative management of clinically localized prostate cancer
    J Adolfsson
    [J]. Prostate Cancer and Prostatic Diseases, 1997, 1 : 59 - 65
  • [6] Conservative management of clinically localized prostate cancer
    Adolfsson, J
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 1997, 1 (02) : 59 - 65
  • [7] The impact of comorbidity on survival among men with localized prostate cancer
    Lu-Yao, G. L.
    Moore, D.
    Shih, W.
    Lin, Y.
    Li, H.
    Albertsen, P. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer
    Albertsen, Peter C.
    Moore, Dirk F.
    Shih, Weichung
    Lin, Yong
    Li, Hui
    Lu-Yao, Grace L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : 1335 - 1341
  • [9] Prostatectomy and survival among men with clinically localized prostate cancer
    Lawrence, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21): : 1724 - 1724
  • [10] Safety of purified isoflavones in men with clinically localized prostate cancer
    Kumar, Nagi B.
    Krischer, Jeffrey P.
    Allen, Kathy
    Riccardi, Diane
    Besterman-Dahan, Karen
    Salup, Raoul
    Kang, Lovellen
    Xu, Ping
    Pow-Sang, Julio
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2007, 59 (02): : 169 - 175